NASDAQ : ACRS

Aclaris Therapeutics, Inc.

$5.6 USD

$0.17 (3.13%)

Volume
6.08M
Average Volume
1.67M
Market Capitalization
$675.33M
P/E Ratio
-10.00
Dividend Yield
0.00%
Price Target
$10.00
Year High
$5.85
Year Low
$1.46
Day High
—
Day Low
—
Payout Ratio
$0.00
Current Ratio
$4.03

ACRS Estimated and Actual Revenue by Quarter

ACRS Estimated and Actual EPS by Quarter

ACRS Analyst Forecasts

Quarter Date No of Estimates Ebitda Ebit
Low High Average Low High Average
2030-12-31 6 -3.33M -283.12K -2M -3.33M -283.12K -2M
2030-09-30 6 -3.33M -283.12K -2M -3.33M -283.12K -2M
2030-06-30 3 -3.33M -283.12K -2M -3.33M -283.12K -2M
2030-03-31 3 -3.33M -283.12K -2M -3.33M -283.12K -2M
2029-12-31 3 -3.33M -283.12K -2M -3.33M -283.12K -2M
2029-09-30 3 -3.33M -283.12K -2M -3.33M -283.12K -2M
Quarter Date No of Estimates NetIncome SgaExpense
Low High Average Low High Average
2030-12-31 6 -66.17M 4.1M -35.45M 528.13K 6.21M 3.72M
2030-09-30 6 -61.03M 3.78M -32.69M 528.13K 6.21M 3.72M
2030-06-30 3 -52.03M 3.22M -27.87M 528.13K 6.21M 3.72M
2030-03-31 3 -47.27M 2.93M -25.32M 528.13K 6.21M 3.72M
2029-12-31 3 -40.61M 2.52M -21.76M 528.13K 6.21M 3.72M
2029-09-30 3 -35.44M 2.19M -18.99M 528.13K 6.21M 3.72M
Quarter Date No of Revenue Estimates Revenue No of EPS Estimates EPS
Low High Average Low High Average
2030-12-31 6 283.12K 3.33M 2M 5 -0.51371 0.0318139 -0.2752
2030-09-30 6 283.12K 3.33M 2M 5 -0.47376 0.02934 -0.2538
2030-06-30 3 283.12K 3.33M 2M 2 -0.40395 0.02501645 -0.2164
2030-03-31 3 283.12K 3.33M 2M 2 -0.36699 0.02272752 -0.1966
2029-12-31 3 283.12K 3.33M 2M 2 -0.31528 0.01952532 -0.1689
2029-09-30 3 283.12K 3.33M 2M 2 -0.27515 0.01703986 -0.1474